Welcome to our dedicated page for N2OFF SEC filings (Ticker: NITO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The N2OFF, Inc. (NASDAQ: NITO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures, offering a structured view of how this clean tech and cleantech issuer reports its activities in renewable energy, agri-tech, and biotechnology. N2OFF files as a Nevada corporation under Commission File Number 001-40403, and its Forms 8-K, proxy statements, and related exhibits provide detailed information on material agreements, corporate actions, and subsidiary operations.
Recent Form 8-K filings describe N2OFF’s acquisition of MitoCareX Bio Ltd., a biotechnology company focused on drug discovery targeting cancer therapeutics via the mitochondrial SLC25 protein family, and the subsequent filing of an amended 8-K/A with supplemental business descriptions, risk factors, and pro forma financial information. Other 8-Ks outline the one-for-thirty-five reverse stock split of N2OFF’s common stock, Nasdaq notifications regarding minimum bid price compliance, and loan and partnership agreements supporting EU-based solar and battery storage projects developed with Solterra Renewable Energy Ltd.
Another key 8-K details a Securities Exchange Agreement with Voice Assist, Inc., under which N2OFF agreed to transfer all of its approximately 98% stake in Save Foods Ltd., an Israeli post-harvest treatment company, in exchange for equity and additional consideration structured through a services agreement. Additional filings report unregistered sales of equity securities, outcomes of annual and special stockholder meetings, and amendments to share incentive plans.
On Stock Titan, investors can review these filings alongside AI-powered summaries that explain the core terms of each document, highlight significant business changes, and clarify how transactions affect N2OFF’s structure and focus areas. Users can quickly scan material event disclosures, equity issuance details, and governance matters to understand how N2OFF manages its RTB solar portfolio, MitoCareX biotech platform, and evolving relationship with Save Foods.
Nexentis Technologies Inc. reported that on February 20, 2026, it issued 600,000 shares of common stock to consultants as payment for investor relations and business development services. The company treated this as a private, unregistered equity issuance relying on the Section 4(a)(2) exemption from the Securities Act.
N2OFF, Inc. is changing its corporate name to Nexentis Technologies Inc. and its Nasdaq trading symbol from NITO to NXTS, effective on the Nasdaq Capital Market on February 26, 2026. The change was approved by the board and implemented through a Nevada charter amendment that did not require shareholder approval.
The company states that the name and brand now reflect its evolution into an AI and data-driven computational biotech platform centered on mitochondrial biology, precision oncology and inflammatory metabolic diseases, built around its wholly owned subsidiary MitoCareX Bio Ltd. It will continue to manage its European RTB solar projects and majority stake in Save Foods Ltd. as part of a broader portfolio. The filing notes that existing stockholder rights and the common stock CUSIP number remain unchanged and that no stockholder action is required.
N2OFF, Inc. Amendment No. 1: Ciro Leonardo Pierri reports beneficial ownership of 227,064 common shares, representing 4.44% of the class based on 5,111,362 shares outstanding as of February 23, 2026. The filing states these shares are held directly by the reporting person.
Ciro Leonardo Pierri reported a passive ownership stake in N2OFF, Inc. He beneficially owns 227,064 shares of N2OFF common stock, representing 5.03% of the class, based on 4,511,362 shares outstanding as of February 12, 2026. Pierri has sole voting and dispositive power over all reported shares and certified that the holdings were not acquired to change or influence control of the company.
Zakai Shlomo reported acquisition or exercise transactions in a Form 4 filing for NITO. The filing lists transactions totaling 50,000 shares. Following the reported transactions, holdings were 64,778 shares.
Barda Lital reported acquisition or exercise transactions in a Form 4 filing for NITO. The filing lists transactions totaling 50,000 shares. Following the reported transactions, holdings were 64,370 shares.
Weiss Amitay reported acquisition or exercise transactions in this Form 4 filing.
N2OFF, Inc. reported that a trust associated with director Amitay Weiss was granted 116,286 restricted shares of common stock on February 9, 2026. The award was issued in accordance with the Save Foods, Inc. 2022 Share Incentive Plan and increased the trust’s indirect holdings to 129,144 shares.
N2OFF, Inc. reported an insider equity award for its Chief Executive Officer, David Palach. On February 9, 2026, a trust associated with him acquired 100,000 restricted shares of common stock at $0 per share under the Save Foods, Inc. 2022 Share Incentive Plan, bringing his indirectly held beneficial ownership to 129,144 shares.
N2OFF, Inc. has agreed to transfer all of its ordinary shares of its majority-owned subsidiary Save Foods Ltd., representing approximately 98% of Save Foods’ issued and outstanding share capital, to Voice Assist, Inc. under a Securities Exchange Agreement. In return, N2OFF will receive Voice Assist common stock equal to 19.99% of Voice Assist on a fully diluted basis, calculated immediately after closing. The closing is expected within 90 calendar days of the agreement, subject to customary conditions.
Separately, N2OFF entered a Services Agreement to provide non-exclusive advisory and support services to Voice Assist. As consideration, N2OFF is entitled to deferred cash of up to $1,000,000 funded from future Voice Assist financings over five years, royalties on gross profit from defined “New Future Projects” (75% for the first three years, 15% for years four through ten, and 5% thereafter), and 75% of any “Ecolab Gross Proceeds” tied to an “Ecolab Claim.” The equity issued in these transactions will rely on the Regulation S registration exemption.
N2OFF, Inc. reported that on January 8, 2026 it issued 35,000 shares of its common stock to a consultant under a new consulting agreement. The shares were provided as consideration for investor relations services, meaning the consultant was paid in stock rather than cash for this work.
The company states that this issuance was an unregistered sale of equity securities and was made in reliance on Section 4(a)(2) of the Securities Act of 1933, which allows transactions by an issuer that do not involve a public offering.